Merck (MRK) Beats on Q3 Earnings & Sales, Raises '19 View
Merck & Co., Inc. MRK reported third-quarter 2019 adjusted earnings of $1.51 per share, which beat the Zacks Consensus Estimate of $1.25. Earnings rose 27% year over year on a reported basis as well as excluding the impact of currency.
Including acquisition- and divestiture-related costs, restructuring costs and certain other items, earnings per share were 74 cents compared with 73 cents in the year-ago quarter.
Revenues for the quarter rose 15% year over year to $12.4 billion, beating the Zacks Consensus Estimate of $11.7 billion. Currency movement negatively impacted revenues by 1%. Excluding currency impact, sales rose 16% year over year.
...
https://finance.yahoo.com/news/merck-mrk...02459.html
Merck & Co., Inc. MRK reported third-quarter 2019 adjusted earnings of $1.51 per share, which beat the Zacks Consensus Estimate of $1.25. Earnings rose 27% year over year on a reported basis as well as excluding the impact of currency.
Including acquisition- and divestiture-related costs, restructuring costs and certain other items, earnings per share were 74 cents compared with 73 cents in the year-ago quarter.
Revenues for the quarter rose 15% year over year to $12.4 billion, beating the Zacks Consensus Estimate of $11.7 billion. Currency movement negatively impacted revenues by 1%. Excluding currency impact, sales rose 16% year over year.
...
https://finance.yahoo.com/news/merck-mrk...02459.html
__________________